3-Propan-2-ylthiane 1,1-dioxide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻烷
• 英文名称: 3-Propan-2-ylthiane 1,1-dioxide
• 英文别名: 3-propan-2-ylthiane 1,1-dioxide
• 化学式: C₈H₁₆O₂S
• 分子量: 176.28
• InChiKey: BJORGUARVDOWMG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• SUBSTITUTED 3-PHENYLPROPYLAMINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISEASES AND DISORDERS
  申请人：Acucela Inc.

  公开号：US20160229831A1

  公开（公告）日：2016-08-11

  The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are substituted 3-phenylpropylamine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compositions are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

  本发明涉及治疗神经退行性疾病和疾病的组合物和方法，特别是眼科疾病和疾病。本文提供了替代的3-苯基丙胺衍生物化合物和包含该化合物的药物组合物。所述组合物对于治疗和预防眼科疾病和疾病，包括年龄相关性黄斑变性（AMD）和Stargardt病具有用处。
• [EN] MALT-1 MODULATORS<br/>[FR] MODULATEURS DE MALT-1
  申请人：EXSCIENTIA LTD

  公开号：WO2022106857A1

  公开（公告）日：2022-05-27

  Disclosed are compounds, compositions and methods for treating disease, syndromes, conditions and disorders that are affected by the modulation of MALT-1. Such compounds are represented by Formula (I) and Formula (II), wherein the variables are defined herein.

  本发明涉及通过调节MALT-1影响的治疗疾病、综合症、病况和疾患的化合物、组合物和方法。这些化合物由公式（I）和公式（II）所表示，其中变量在此定义。
• [EN] TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS<br/>[FR] HÉTÉROCYCLES TRICYCLIQUES UTILES EN TANT QU'INHIBITEURS DE FGFR
  申请人：INCYTE CORP

  公开号：WO2022261159A1

  公开（公告）日：2022-12-15

  The present disclosure relates to tricyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR enzyme and are useful in the treatment of FGFR-associated diseases such as cancer.

  本公开涉及三环杂环化合物及其药物组合物，其是FGFR酶的抑制剂，并且在治疗FGFR相关疾病如癌症方面有用。
• US20140275043A1
  申请人：——

  公开号：US20140275043A1

  公开（公告）日：2014-09-18
• COMPOUNDS FOR USE IN PREPARING HETEROCYCLIC TRIAZOLE AGONISTS OF THE APJ RECEPTOR
  申请人：AMGEN INC.

  公开号：US20180222895A1

  公开（公告）日：2018-08-09

  Compounds of Formula V, salts thereof, tautomers thereof, and salts of the tautomers have the following structure and are useful compounds in preparing small molecule agonists of the APJ Receptor: where the definitions of the variables are provided herein.